Intermittent Fasting for Pancreatitis (NCT04760847) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Intermittent Fasting for Pancreatitis
United States64 participantsStarted 2026-03
Plain-language summary
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 year
* Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by:
abdominal pain and either amylase or lipase \> 3 x the upper limit of normal, imaging suggestive of, separated by time
* Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
* Pancreatic exocrine insufficiency defined by a pancreatic elastase \< 200 ug/g stool10
Exclusion Criteria:
* Age \< 18 years
* Pregnant Patients
* Age \> 80 years
* Patients who cannot consent for themselves
* Glycogen storage disease
* Insulinoma or hypoglycemic state
* Active alcohol abuse
* Alcohol induced acute pancreatitis
* Gallstone induced acute pancreatitis
* Pancreatic solid neoplasm
* Patients with diabetes
* Patients on beta blockers
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is testing intermittent fasting for pancreatitis — given my specific type (acute, chronic, or recurrent), does my doctor think a fasting-based approach would be appropriate or potentially risky for my situation?
2The trial is listed as 'not yet recruiting' — can my doctor find out when it might open, which sites will be involved, and whether it would even be realistic for me to participate once it does?
3The main thing this trial is measuring is a quality-of-life score called PANQALI — does that mean the study isn't primarily focused on reducing the number of attacks or improving my organ function, and how does that affect whether the results would be meaningful for my goals?
4Since this trial is listed as Phase NA, meaning it may be more exploratory in nature, what does my doctor think is currently known about the safety of intermittent fasting specifically for people with pancreatic disease, where diet changes can sometimes trigger complications?
5Are there established dietary or treatment approaches for my type of pancreatitis that my doctor would recommend trying first, before considering an investigational fasting study like this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pancreas related Quality of Life Index (PANQALI)
Timeframe: 24 weeks
Trial details
NCT IDNCT04760847
SponsorH. Lee Moffitt Cancer Center and Research Institute